Genetic variants of <i>CYP2C19</i> and <i>CYP2C18</i> and their clinical implications in the Saudi population. [PDF]
Alkattan A +4 more
europepmc +1 more source
Influence of combined CYP2C19 and CYP2D6 phenotypes on adverse drug reactions in patients with major depressive disorder: a clinical cohort study. [PDF]
Görnert C +6 more
europepmc +1 more source
Factors affecting voriconazole pharmacokinetic variability in critically ill patients: a systematic review. [PDF]
Coste A +5 more
europepmc +1 more source
Including Vonoprazan With PPIs Challenges the Drug-Interaction Hypothesis. [PDF]
Shamsulddin AB.
europepmc +1 more source
Effect of Individual and Combined Cytochrome P450 Activity Scores on Symptom Improvement and Side Effects in Youth Treated With Sertraline. [PDF]
Gerlach S +7 more
europepmc +1 more source
Challenges and prospects of <i>CYP2C19</i> genotype-guided clopidogrel therapy from the perspective of precision medicine. [PDF]
Wang Z, Fu X, Zhang G.
europepmc +1 more source
CYPRI: a clinical decision-making tool to select psychiatric patients for pharmacogenetic testing. [PDF]
Tašková I, Šafářová N, Hahn M.
europepmc +1 more source
The Role of Pharmacogenetics in the Effectiveness of Rheumatoid Arthritis Treatment with Leflunomide. [PDF]
Plewa P +5 more
europepmc +1 more source
Integrating CRISPR functional genomics with admixture-aware psychotropic pharmacogenetics in Brazil. [PDF]
Rodrigues BB +4 more
europepmc +1 more source

